XOMA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.41 USD | +0.20% |
|
-0.27% | +37.35% |
| 04-03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
| 03-08 | XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 266.4 | 486.4 | 235.8 | 210.7 | 212.5 | 295.6 | - | - |
| Enterprise Value (EV) 1 | 266.4 | 486.4 | 235.8 | 210.7 | 212.5 | 295.6 | 295.6 | 295.6 |
| P/E ratio | -119 x | 56.6 x | 32.1 x | -9.29 x | -4.58 x | -11.9 x | -14.9 x | -27.3 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 14.5 x | 16.6 x | 6.18 x | 35 x | 44.7 x | 21 x | 14.3 x | 9.65 x |
| EV / Revenue | 14.5 x | 16.6 x | 6.18 x | 35 x | 44.7 x | 21 x | 14.3 x | 9.65 x |
| EV / EBITDA | -69 x | 39.1 x | 13.4 x | -12.1 x | -5.19 x | -15.8 x | -19.2 x | -49.3 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 9,758 | 11,022 | 11,311 | 11,451 | 11,488 | 11,635 | - | - |
| Reference price 2 | 27.30 | 44.13 | 20.85 | 18.40 | 18.50 | 25.41 | 25.41 | 25.41 |
| Announcement Date | 20-03-10 | 21-03-10 | 22-03-08 | 23-03-09 | 24-03-08 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 18.37 | 29.38 | 38.16 | 6.027 | 4.758 | 14.1 | 20.65 | 30.65 |
| EBITDA 1 | -3.86 | 12.44 | 17.54 | -17.41 | -40.95 | -18.7 | -15.4 | -6 |
| EBIT 1 | -3.885 | 12.42 | 17.53 | -17.41 | -41.85 | -12.9 | -8.35 | -0.35 |
| Operating Margin | -21.15% | 42.25% | 45.94% | -288.93% | -879.53% | -91.49% | -40.44% | -1.14% |
| Earnings before Tax (EBT) 1 | -1.982 | 11.8 | 15.89 | -17.12 | -40.83 | -24.85 | -20.15 | -10.85 |
| Net income 1 | -1.982 | 8.793 | 7.787 | -22.58 | -46.3 | -24.9 | -20.2 | -10.9 |
| Net margin | -10.79% | 29.92% | 20.41% | -374.58% | -973.16% | -176.6% | -97.82% | -35.56% |
| EPS 2 | -0.2300 | 0.7800 | 0.6500 | -1.980 | -4.040 | -2.140 | -1.705 | -0.9300 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 20-03-10 | 21-03-10 | 22-03-08 | 23-03-09 | 24-03-08 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.94 | 35.94 | 3.107 | 0.983 | 0.451 | 1.486 | 0.437 | 1.658 | 0.83 | 1.833 | 1.705 | 2.46 | 3.985 | 5.95 |
| EBITDA 1 | -1.345 | 30.37 | -2.063 | -4.766 | -4.368 | -6.21 | -9.944 | -5.732 | -5.563 | -19.71 | -5.3 | -5 | -4.6 | -3.8 |
| EBIT 1 | -3.345 | 30.36 | -2.065 | -4.767 | -4.372 | -6.21 | -10.17 | -5.957 | -5.787 | -19.93 | -4.95 | -4.3 | -2.8 | -0.9 |
| Operating Margin | -355.85% | 84.48% | -66.46% | -484.94% | -969.4% | -417.9% | -2,327.23% | -359.29% | -697.23% | -1,087.51% | -290.32% | -174.8% | -70.26% | -15.13% |
| Earnings before Tax (EBT) 1 | -4.436 | 29.94 | -2.28 | -4.67 | -4.178 | -5.991 | -9.813 | -5.4 | -5.509 | -20.11 | -7.8 | -7 | -5.65 | -4.3 |
| Net income 1 | -5.804 | 19.74 | -3.648 | -6.038 | -5.546 | -7.344 | -11.18 | -6.768 | -6.877 | -21.48 | -9.2 | -8.4 | -6.95 | -5.65 |
| Net margin | -617.45% | 54.93% | -117.41% | -614.24% | -1,229.71% | -494.21% | -2,558.58% | -408.2% | -828.55% | -1,171.69% | -539.59% | -341.46% | -174.4% | -94.96% |
| EPS 2 | -0.5100 | 1.670 | -0.3200 | -0.5300 | -0.4800 | -0.6400 | -0.9800 | -0.5900 | -0.6000 | -1.870 | -0.7900 | -0.7200 | -0.6000 | -0.4850 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-11-04 | 22-03-08 | 22-05-05 | 22-08-04 | 22-11-03 | 23-03-09 | 23-05-09 | 23-08-08 | 23-11-07 | 24-03-08 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - | - |
| Announcement Date | 20-03-10 | 21-03-10 | 22-03-08 | 23-03-09 | 24-03-08 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
25.41
USD
Average target price
74
USD
Spread / Average Target
+191.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +37.35% | 296M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- XOMA Stock
- Financials XOMA Corporation
